-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OcwFfXOGeqdSspUu2YU+6Ea93foJrKJk6fzH5e61lWh8lb8Ri9ktpeEU8uUmzFFs mxSTpelQAa9i1uWXav+YQg== 0000937889-04-000004.txt : 20040412 0000937889-04-000004.hdr.sgml : 20040412 20040412154523 ACCESSION NUMBER: 0000937889-04-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040408 FILED AS OF DATE: 20040412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEMORY PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001062216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES CENTRAL INDEX KEY: 0000937889 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50642 FILM NUMBER: 04728587 BUSINESS ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 2126495600 MAIL ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 4 1 edgar.xml PRIMARY DOCUMENT X0201 4 2004-04-08 1 0001062216 MEMORY PHARMACEUTICALS CORP MEMY 0000937889 VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK NY 10112 0 0 1 0 Common Stock 2004-04-08 4 C 0 204762 A 204762 D Common Stock 2004-04-08 4 C 0 140064 A 344826 D Common Stock 2004-04-08 4 C 0 190697 A 535523 D Series B Convertible Preferred Stock 2004-04-08 4 C 0 614286 D Common Stock 204762 0 D Series C Convertible Preferred Stock 2004-04-08 4 C 0 393600 D Common Stock 140064 0 D Series D Convertible Preferred Stock 2004-04-08 4 C 0 572093 D Common Stock 190697 0 D The shares of each Series of Preferred Stock were convertible into the number of shares of Common Stock indicated, and upon the closing of the Issuer's initial public offering of Common Stock, all such shares of Preferred Stock were automatically converted into the number of shares of Common Stock indicated. Upon the closing of the Issuer's initial public offering, each share of Series B Convertible Preferred Stock automatically converted into 0.3333 shares of the Issuer's Common Stock. Not applicable. Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock automatically converted into 0.3559 shares of the Issuer's Common Stock. Upon the closing of the Issuer's initial public offering, each share of Series D Convertible Preferred Stock automatically converted into 0.3333 shares of the Issuer's Common Stock. Anthony B. Evnin, General Partner 2004-04-12 -----END PRIVACY-ENHANCED MESSAGE-----